Use of nonsteroidal anti-inflammatory drugs and coxibs in the elderly. Are we following the guidelines?

Clinical Rheumatology

Volumn 27, Issue 9, 2008, Pages 1081-1082

  Duran Barragan, Sergio ^a   Russell, Anthony S ^b  

^a Unidad de Investigacion en Enfermedades Cronico Degenerativas   (Mexico)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

Coxibs; Elderly; Guidelines; Nonsteroidal Anti inflammatory drugs

Indexed keywords

ACETYLSALICYLIC ACID; CYCLOOXYGENASE 2 INHIBITOR; NONSTEROID ANTIINFLAMMATORY AGENT; PROTON PUMP INHIBITOR; SEROTONIN UPTAKE INHIBITOR; WARFARIN;

AGE; CANADA; CARDIOVASCULAR DISEASE; COMORBIDITY; CONSENSUS DEVELOPMENT; DRUG CONTRAINDICATION; DRUG EFFICACY; DRUG SAFETY; DRUG TOLERABILITY; DRUG USE; EDITORIAL; ELDERLY CARE; HEALTH CARE QUALITY; HIGH RISK PATIENT; HUMAN; KIDNEY DISEASE; LOW DRUG DOSE; MEDICAL DECISION MAKING; MEDICAL PRACTICE; MEDICATION ERROR; OSTEOARTHRITIS; PHARMACEUTICAL CARE; POLYPHARMACY; PRACTICE GUIDELINE; PRESCRIPTION; PRIORITY JOURNAL; RHEUMATIC DISEASE; RHEUMATOID ARTHRITIS; STOMACH DISEASE; STOMACH PROTECTION; SYSTEMIC THERAPY;

AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; CYCLOOXYGENASE 2 INHIBITORS; GUIDELINES AS TOPIC; HUMANS; RHEUMATIC DISEASES;

EID: 48449089236     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-008-0959-0     Document Type: Editorial

References (15)

1. Chen YF, Jobanputra P, Barton P et al (2008) Cyclooxygenase-2 selective non-steroidal anti-inflammatory drugs (etodolac, meloxicam, celecoxib, rofecoxib, etoricoxib, valdecoxib and lumiracoxib) for osteoarthritis and rheumatoid arthritis: A systematic review and economic evaluation. Health Technol Assess 12:1-178
2. Abraham NS, El-Serag HB, Johnson ML et al (2005) National adherence to evidence-based guidelines for the prescription of nonsteroidal anti-inflammatory drugs. Gastroenterology 129:1171-1178
3. Tannenbaum H, Bombardier C, Davis P et al (2006) An evidence-based approach to prescribing nonsteroidal anti-inflammatory drugs. Third Canadian Consensus Conference. J Rheumatol 33:140-157
4. McLean AJ, Le Couteur DG (2004) Aging biology and geriatric clinical pharmacology. Pharmacol Rev 56:163-184
5. Turnheim K (2004) Drug therapy in the elderly. Exp Gerontol 39:1731-1738
6. Skeith KJ, Wright M, Davis P (1994) Differences in NSAID tolerability profiles. Fact or fiction? Drug Saf 10:183-195
7. Jorgensen T, Johansson S, Kennerfalk A et al (2001) Prescription drug use, diagnoses, and healthcare utilization among the elderly. Ann Pharmacother 35:1004-1009
8. Kennerfalk A, Ruigomez A, Wallander MA et al (2002) Geriatric drug therapy and healthcare utilization in the United Kingdom. Ann Pharmacother 36:797-803
9. Homik JE, Suarez-Almazor ME (2000) Clinical guidelines: A must for rheumatology? Baillieres Best Pract Res Clin Rheumatol 14:649-661
10. Juby AG, Davis P (2008) Utility of published guidelines on the use of nonsteroidal anti-inflammatory drugs in the elderly. Clin Rheumatol doi: 10.1007/s10067-008-0952-7
11. Rahme E, Barkun A, Nedjar H et al (2008) Hospitalizations for upper and lower GI events associated with traditional NSAIDs and acetaminophen among the elderly in Quebec, Canada. Am J Gastroenterol 103:872-882
12. Zhan C, Sangl J, Bierman AS et al (2001) Potentially inappropriate medication use in the community-dwelling elderly: Findings from the 1996 Medical Expenditure Panel Survey. JAMA 286:2823-2829
13. Visser LE, Graatsma HH, Stricker BH (2002) Contraindicated NSAIDs are frequently prescribed to elderly patients with peptic ulcer disease. Br J Clin Pharmacol 53:183-188
14. Rochon PA, Lane CJ, Bronskill SE et al (2004) Potentially inappropriate prescribing in Canada relative to the US. Drugs Aging 21:939-947
15. Greco PJ, Eisenberg JM (1993) Changing physicians' practices. N Engl J Med 329:1271-1273